308 related articles for article (PubMed ID: 26982597)
1. Altered gut microbiota profile in common variable immunodeficiency associates with levels of lipopolysaccharide and markers of systemic immune activation.
Jørgensen SF; Trøseid M; Kummen M; Anmarkrud JA; Michelsen AE; Osnes LT; Holm K; Høivik ML; Rashidi A; Dahl CP; Vesterhus M; Halvorsen B; Mollnes TE; Berge RK; Moum B; Lundin KE; Fevang B; Ueland T; Karlsen TH; Aukrust P; Hov JR
Mucosal Immunol; 2016 Nov; 9(6):1455-1465. PubMed ID: 26982597
[TBL] [Abstract][Full Text] [Related]
2. Chronic immune activation in common variable immunodeficiency (CVID) is associated with elevated serum levels of soluble CD14 and CD25 but not endotoxaemia.
Litzman J; Nechvatalova J; Xu J; Ticha O; Vlkova M; Hel Z
Clin Exp Immunol; 2012 Dec; 170(3):321-32. PubMed ID: 23121673
[TBL] [Abstract][Full Text] [Related]
3. Gut Microbiota-Dependent Trimethylamine N-Oxide Associates With Inflammation in Common Variable Immunodeficiency.
Macpherson ME; Hov JR; Ueland T; Dahl TB; Kummen M; Otterdal K; Holm K; Berge RK; Mollnes TE; Trøseid M; Halvorsen B; Aukrust P; Fevang B; Jørgensen SF
Front Immunol; 2020; 11():574500. PubMed ID: 33042155
[TBL] [Abstract][Full Text] [Related]
4. Bacterial but Not Fungal Gut Microbiota Alterations Are Associated With Common Variable Immunodeficiency (CVID) Phenotype.
Fiedorová K; Radvanský M; Bosák J; Grombiříková H; Němcová E; Králíčková P; Černochová M; Kotásková I; Lexa M; Litzman J; Šmajs D; Freiberger T
Front Immunol; 2019; 10():1914. PubMed ID: 31456808
[TBL] [Abstract][Full Text] [Related]
5. Rifaximin alters gut microbiota profile, but does not affect systemic inflammation - a randomized controlled trial in common variable immunodeficiency.
Jørgensen SF; Macpherson ME; Bjørnetrø T; Holm K; Kummen M; Rashidi A; Michelsen AE; Lekva T; Halvorsen B; Trøseid M; Mollnes TE; Berge RK; Yndestad A; Ueland T; Karlsen TH; Aukrust P; Hov JR; Fevang B
Sci Rep; 2019 Jan; 9(1):167. PubMed ID: 30655568
[TBL] [Abstract][Full Text] [Related]
6. Gut Microbiome and Common Variable Immunodeficiency: Few Certainties and Many Outstanding Questions.
Varricchi G; Poto R; Ianiro G; Punziano A; Marone G; Gasbarrini A; Spadaro G
Front Immunol; 2021; 12():712915. PubMed ID: 34408753
[TBL] [Abstract][Full Text] [Related]
7. Fecal Immunoglobulin Levels as a Modifier of the Gut Microbiome in Patients with Common Variable Immunodeficiency.
Nöltner C; Bulashevska A; Hübscher K; Haberstroh H; Grimbacher B; Proietti M
J Clin Immunol; 2023 Aug; 43(6):1208-1220. PubMed ID: 36961604
[TBL] [Abstract][Full Text] [Related]
8. Increased Plasma Levels of Triglyceride-Enriched Lipoproteins Associate with Systemic Inflammation, Lipopolysaccharides, and Gut Dysbiosis in Common Variable Immunodeficiency.
Macpherson ME; Skarpengland T; Hov JR; Ranheim T; Vestad B; Dahl TB; Fraz MSA; Michelsen AE; Holven KB; Fevang B; Berge RK; Aukrust P; Halvorsen B; Jørgensen SF
J Clin Immunol; 2023 Aug; 43(6):1229-1240. PubMed ID: 36995502
[TBL] [Abstract][Full Text] [Related]
9. Microbial Dysbiosis in Common Variable Immune Deficiencies: Evidence, Causes, and Consequences.
Berbers RM; Nierkens S; van Laar JM; Bogaert D; Leavis HL
Trends Immunol; 2017 Mar; 38(3):206-216. PubMed ID: 28017520
[TBL] [Abstract][Full Text] [Related]
10. Gut Antibody Deficiency in a Mouse Model of CVID Results in Spontaneous Development of a Gluten-Sensitive Enteropathy.
Mohammed AD; Khan MAW; Chatzistamou I; Chamseddine D; Williams-Kang K; Perry M; Enos R; Murphy A; Gomez G; Aladhami A; Oskeritzian CA; Jolly A; Chang Y; He S; Pan Z; Kubinak JL
Front Immunol; 2019; 10():2484. PubMed ID: 31708923
[TBL] [Abstract][Full Text] [Related]
11. Patients With Common Variable Immunodeficiency (CVID) Show Higher Gut Bacterial Diversity and Levels of Low-Abundance Genes Than the Healthy Housemates.
Bosák J; Lexa M; Fiedorová K; Gadara DC; Micenková L; Spacil Z; Litzman J; Freiberger T; Šmajs D
Front Immunol; 2021; 12():671239. PubMed ID: 34054845
[TBL] [Abstract][Full Text] [Related]
12. Gut microbiota in Mexican patients with common variable immunodeficiency.
Franco-Esquivias AP; Peña CG; Torres-Lozano C; Vaca-Paniagua F; Díaz-Velásquez C; Ortega-Cisneros M; Quintero-Ramos A
Gac Med Mex; 2019; 155(5):447-452. PubMed ID: 32091022
[TBL] [Abstract][Full Text] [Related]
13. Impaired HDL Function Amplifies Systemic Inflammation in Common Variable Immunodeficiency.
Macpherson ME; Halvorsen B; Yndestad A; Ueland T; Mollnes TE; Berge RK; Rashidi A; Otterdal K; Gregersen I; Kong XY; Holven KB; Aukrust P; Fevang B; Jørgensen SF
Sci Rep; 2019 Jul; 9(1):9427. PubMed ID: 31263122
[TBL] [Abstract][Full Text] [Related]
14. Dysimmunity in common variable immunodeficiency is associated with alterations in oral, respiratory, and intestinal microbiota.
Cabanero-Navalon MD; Garcia-Bustos V; Mira A; Moral Moral P; Salavert-Lleti M; Forner Giner MJ; Núñez Beltrán M; Todolí Parra J; Bracke C; Carda-Diéguez M
Clin Immunol; 2023 Nov; 256():109796. PubMed ID: 37774905
[TBL] [Abstract][Full Text] [Related]
15. Monocyte activation is a feature of common variable immunodeficiency irrespective of plasma lipopolysaccharide levels.
Barbosa RR; Silva SP; Silva SL; Tendeiro R; Melo AC; Pedro E; Barbosa MP; Santos MC; Victorino RM; Sousa AE
Clin Exp Immunol; 2012 Sep; 169(3):263-72. PubMed ID: 22861366
[TBL] [Abstract][Full Text] [Related]
16. Altered Microbiota, Impaired Quality of Life, Malabsorption, Infection, and Inflammation in CVID Patients With Diarrhoea.
van Schewick CM; Nöltner C; Abel S; Burns SO; Workman S; Symes A; Guzman D; Proietti M; Bulashevska A; Moreira F; Soetedjo V; Lowe DM; Grimbacher B
Front Immunol; 2020; 11():1654. PubMed ID: 32849570
[No Abstract] [Full Text] [Related]
17. Convergence of cytokine dysregulation and antibody deficiency in common variable immunodeficiency with inflammatory complications.
Abyazi ML; Bell KA; Gyimesi G; Baker TS; Byun M; Ko HM; Cunningham-Rundles C; Feng F; Maglione PJ
J Allergy Clin Immunol; 2022 Jan; 149(1):315-326.e9. PubMed ID: 34146579
[TBL] [Abstract][Full Text] [Related]
18. Altered Plasma Fatty Acids Associate with Gut Microbial Composition in Common Variable Immunodeficiency.
Skarpengland T; Macpherson ME; Hov JR; Kong XY; Bohov P; Halvorsen B; Fevang B; Berge RK; Aukrust P; Jørgensen SF
J Clin Immunol; 2022 Jan; 42(1):146-157. PubMed ID: 34669143
[TBL] [Abstract][Full Text] [Related]
19. Immune/microbial interface perturbation in human IgA deficiency.
Sterlin D; Fieschi C; Malphettes M; Larsen M; Gorochov G; Fadlallah J
Gut Microbes; 2019; 10(3):429-433. PubMed ID: 30449244
[TBL] [Abstract][Full Text] [Related]
20. CVID enteropathy is characterized by exceeding low mucosal IgA levels and interferon-driven inflammation possibly related to the presence of a pathobiont.
Shulzhenko N; Dong X; Vyshenska D; Greer RL; Gurung M; Vasquez-Perez S; Peremyslova E; Sosnovtsev S; Quezado M; Yao M; Montgomery-Recht K; Strober W; Fuss IJ; Morgun A
Clin Immunol; 2018 Dec; 197():139-153. PubMed ID: 30240602
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
